American Society of Hematology

2016 ASH® Meeting on Hematologic Malignancies

September 16-17, 2016
Fairmont Chicago, Millennium Park, Chicago, IL

 Add to calendar 09/16/2016 07:00 AM09/17/2016 08:00 PMASH Meeting on Hematologic MalignanciesHear the top experts in hematologic malignancies discuss the latest developments in clinical care and find answers to your most challenging patient care questions.Fairmont Chicago, Millennium Park, Chicago, ILMM/DD/YYYY129600
     Get email updates

Registration for the ASH® Meeting on Hematologic Malignancies (MHM) is now open.

Register now

Attend the 2016 ASH Meeting on Hematologic Malignancies to hear world-class experts in hematologic malignancies discuss the latest developments in clinical care, and learn how experts in the field treat their own patients based on the available data.

The majority of the program content will be structured as “How I Treat” sessions on core malignancies, including leukemia, lymphoma, myelodysplastic syndromes, myeloma, and myeloproliferative neoplasms. Each presentation will showcase the speaker's evidence-based treatment approaches, ranging from standard of care, specialized disease complications, and novel agent discussions. The meeting will also feature topic-based panel discussions which will allow participants to get answers to their most challenging patient care questions.

Program Co-Chairs

Kenneth C_ Anderson, MD

Kenneth C. Anderson, MD
Dana-Farber Cancer

Joseph M_ Connors, MD

Joseph M. Connors, MD
Vancouver Clinic, British Columbia Cancer Agency

Martin S_ Tallman, MD

Martin S. Tallman, MD
Memorial Sloan-Kettering Cancer Center

Program Planning Committee

  • Kenneth C. Anderson, MD, Dana-Farber Cancer Institute
  • Hetty Carraway, MD, Cleveland Clinic
  • Joseph M. Connors, MD, British Columbia Cancer Agency
  • Brad Kahl, MD, Washington University in St. Louis
  • Ruben A. Mesa, MD, Mayo Clinic
  • Wendy Stock, MD, University of Chicago
  • Martin S. Tallman, MD, Memorial Sloan Kettering Cancer Center

Partner Organizations

  • Alabama Cancer Congress (ACC)
  • Asociación de Hematología y Oncología Médica de Puerto Rico
  • Denali Oncology Group
  • Florida Society of Clinical Oncology (FLASCO)
  • Hawaii Society of Clinical Oncology (HSCO)
  • Idaho Society of Clinical Oncology (ISCO)
  • Illinois Medical Oncology Society (IMOS)
  • Indiana Oncology Society (IOS)
  • Iowa Oncology Society (IOS)
  • Kansas Society of Clinical Oncology (KSCO)
  • Louisiana Oncology Society (LOS)
  • Maryland and DC Society of Clinical Oncology (MDCSCO)
  • Massachusetts Society of Clinical Oncologists (MSCO)
  • Medical Oncology Association of Southern California (MOASC)
  • Minnesota Society of Clinical Oncology (MSCO)
  • Mississippi Oncology Society (MOS)
  • Missouri Oncology Society (MOS)
  • Montana State Oncology Society (MSOS)
  • Nebraska Oncology Society (NOS)
  • Nevada Oncology Society (NOS)
  • North Carolina Oncology Association (NCOA)
  • Oklahoma Society of Clinical Oncology (OSCO)
  • Pennsylvania Society of Oncology and Hematology (PSOH)
  • Rocky Mountain Oncology Society (RMOS)
  • Society of Utah Medical Oncologists (SUMO)
  • South Carolina Oncology Society (SCOS)
  • Tennessee Oncology Practice Society (TOPS)
  • Texas Society of Clinical Oncology (TxSCO)
  • The Arizona Clinical Oncology Society (TACOS)
  • Virginia Association of Hematologist and Oncologist (VAHO)
  • Washington State Medical Oncology Society (WSMOS)
  • West Virginia Oncology Society (WVOS)
  • Wisconsin Association of Hematology and Oncology (WAHO)

Looking for Information on the 2015 Meeting?

Thank you for attending the inaugural ASH Meeting on Hematologic Malignancies. If you missed the event or would like to experience the meeting again, you can order the full meeting webcast at ASH On Demand, with over 15 hours of educational content from 25 sessions and 9 panel discussions.

Corporate Support

  • Incyte Corporation
  • Takeda Oncology
  • Teva Oncology

If your company is interested in sponsoring and/or exhibiting at this meeting, contact Thelma Barnett at for more information.

back to top